亿帆医药：关于全资子公司收到药品注册受理通知书的公告

Core Viewpoint - Yifan Pharmaceutical announced that its wholly-owned subsidiary, Sichuan Defeng Pharmaceutical Co., Ltd., has received the acceptance notice for the domestic production registration application of Salbutamol Sulfate Powder from the National Medical Products Administration [2] Group 1 - The acceptance notice indicates a significant step towards the commercialization of Salbutamol Sulfate Powder, which may enhance the company's product portfolio [2] - The approval process reflects the regulatory compliance and potential market entry for the new pharmaceutical product [2]